FRACTION-RCC: Innovative, high-throughput assessment of nivolumab plus ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Choueiri, Toni K
  • Kluger, Harriet M
  • George, Saby
  • Tykodi, Scott S
  • Kuzel, Timothy M
  • Perets, Ruth
  • Nair, Suresh
  • Procopio, Giuseppe
  • Carducci, Michael Anthony
  • Castonguay, Vincent
  • Folefac, Edmund
  • Lee, Chung-Han
  • Hotte, Sebastien
  • Miller, Wilson H
  • Saggi, Shruti S
  • Gold, David
  • Motzer, Robert J
  • Escudier, Bernard

publication date

  • May 20, 2020